News

The aim of Conduent's Maven is to help epidemiologists detect, monitor, track and report health threats.  

OpenAI cofounder Sam Altman says the company "is not for sale."  

Its developer, a spinoff from Nanyang Technological University, Singapore, is looking to raise up to $1.5 million to commercialise their MCI screening tool.

Two U.S. senators and the Partnership for Safe Medicines sent letters to the FDA, raising concerns that the ad fails to disclose safety and side effect information required in pharmaceutical advertising.

The initiative brings together more than 60 companies in Europe and aims to "unlock Europe's full potential in AI."  

The company will use the funds to scale operations and expedite growth in Medicare and ICHRA.

The funding, which is NRFC's first medical science investment, will help introduce the company's AI to more health facilities locally and abroad.

Bipartisan legislation dubbed "No DeepSeek on Government Devices Act" comes amid concerns that the application allows China to see user data.  

Vik Bajaj, CEO of Foresite Labs and managing director of Foresite Capital, discusses how AI is used to develop personalized cancer vaccines - and the challenges and promises of Project Stargate.

Also, a new mobile app in Australia tracks eyelid movement to detect sleep apnoea.